 Sierra Oncology Inc NASDAQ: SRRA shares are trading significantly higher Wednesday after the company announced it will be acquired by GlaxoSmithKline PLC NYSE: GSK for 55 per share in cash, representing an approximate total equity value of 1.9 billion. GSK believes Sierra. 